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Abstract
Background: Previous studies indicate that the UL31 protein and its homology play similar roles
in nuclear egress of all herpesviruses. However, there is no report on the UL31 gene product of
DEV. In this study, we expressed and presented the basic properties of the DEV UL31 product.
Results: The entire ORF of the UL31 was cloned into pET 32a (+) prokaryotic expression vector.
Escherichia coli BL21(DE3) competent cells were transformed with the construct followed by the
induction of protein expression by the addition of IPTG. Band corresponding to the predicted sizes
(55 kDa) was produced on the SDS-PAGE. Over expressed 6×His-UL31 fusion protein was purified
by nickel affinity chromatography. The DEV UL31 gene product has been identified by using a rabbit
polyclonal antiserum raised against the purified protein. A protein of approximate 35 kDa that
reacted with the antiserum was detected in immunoblots of DEV-infected cellular lysates,
suggesting that the 35 kDa protein was the primary translation product of the UL31 gene. RT-PCR
analyses revealed that the UL31 gene was transcribed most abundantly during the late phase of
replication. Subsequently, Immunofluorescence analysis revealed that the protein was widespread
speckled structures in the nuclei of infected cells. Western blotting of purified virion preparations
showed that UL31 was a component of intracellular virions but was absent from mature
extracellular virions. Finally, an Immunofluorescence assay was established to study the distribution
of the UL31 antigen in tissues of artificially DEV infected ducks. The results showed that the UL31
antigen was primarily located in the cells of digestive organs and immunological organs.
Conclusion: In this work, we present the basic properties of the DEV UL31 product. The results
indicate that DEV UL31 shares many similarities with its HSV or PRV homolog UL31 and suggest
that functional cross-complementation is possible between members of the Alphaherpesvirus
subfamily. Furthermore, in vivo experiments with ducks infected with UL31-defective isolates of
DEV will also be of importance in order to assess the possible role of the UL31 protein in viral
pathogenesis. These properties of the UL31 protein provide a prerequisite for further functional
analysis of this gene.
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Background
Duck virus enteritis (DVE) is an acute and contagious dis-
ease of birds from the order Anseriformes (ducks, geese,
and swans) [1-3]. The causative agent of the DVE is Duck
enteritis virus (DEV), a member of the subfamily
Alphaherpesvirinae [4]. As with many other herpesviruses,
DVE can establish inapparent infections in birds that sur-
vive exposure to it, a state referred to as latency [5]. This
makes the disease difficult to monitor and control. The
genome of DEV is composed of a linear, double stranded
DNA and the G+C content is 64.3%, higher than any
other reported avian herpesvirus in the subfamily
Alphaherpesvirinae [6]. There has been little information
about the molecular characteristics of DEV since the dis-
ease was report in 1926. Although the molecular structure
of the genome has not been reported, the DEV genomic
library was successfully constructed in our laboratory [7].
During lytic infection, many herpesvirus proteins are
involved in the early steps of viral maturely at the nuclear
envelope, which include the UL31 of Herps simplex virus
(HSV) and Pseudorabies virus (PRV) [8-11]. The UL31
protein of HSV-1 is a nuclear matrix-associated phospho-
protein stabilized by its interaction with the UL34 protein
[12,13]. The two proteins interact to form a complex colo-
calized at the nuclear rim of infected cells, and become
incorporated into virions during envelopment at the inner
nuclear membrane [13-15]. With many similarities and a
few differences, accumulating evidence indicates that the
UL31 protein and its homology play similar roles in
nuclear egress of Alpha-,  Beta-, and Grammherpesviruses
[8,14,16-20]. However, there is no report on the identifi-
cation and characterization of the UL31 gene product of
DEV.
In the present study, the UL31 gene was amplified from
the genome of DEV and successfully expressed in a
prokaryotic expression system. We prepared polyclonal
antiserum which allowed identifying and characterizing
the UL31 gene product of DEV. We found that the UL31
gene was transcribed most abundantly during the late
phase of replication, and the UL31 protein was approxi-
mately 35 kDa and widespread speckled structures in the
nuclei of infected cells, but was not detectable in purified
virions. In the DEV-infected duck tissues, the UL31 anti-
gen was primarily located in the cells of immunological
organs and digestive organs. These properties of the UL31
protein provide a prerequisite for further functional anal-
ysis of this gene.
Results and discussion
Predicted features of the UL31 ORF
Computer analysis showed that the DEV UL31 potentially
encodes a protein of 35.75 kDa, consisting of 310 amino
acids and with an isoelectric point of 7.56. UL31 is pre-
dicted to be a potential nuclear localization. The sequence
contains 28 possible sites for phosphorylation, 22 on ser-
ine, 2 on threonine, and 4 on tyrosine residues (Fig. 1)
Prediction of Phosphorylation sites of deduced amid acids of the DEV UL31 protein Figure 1
Prediction of Phosphorylation sites of deduced amid acids of the DEV UL31 protein. Potential sites of phosphoryla-
tion were predicted using the NetPhos algorithm available via the Expasy proteomics tools database http://www.expasy.ch.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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[21]. Furthermore, six casein kinase II, three cAMP-
dependent protein kinase, four protein kinase C phospho-
rylation sites and one potential N-linked myristoylation
site are present along the amino acid sequence. As men-
tioned in the introduction, UL31 has been studied exten-
sively in human and nonhuman herpesviruses [9,19,22-
24]. Fig 2, showing the UL31 family members of herpes-
viruses, illustrates that DEV UL31 shares identities of 37%
with EBV BFLF2, 21% with HSV-1 UL31, and 19% with
HCMV UL53, suggesting a potential related function.
Expression and purification of recombinant UL31
In the present study, DNA sequence encoding the UL31
gene was amplified from the genome of DEV (Fig 3B), and
cloned into the fusion expression vector pET-32a (+) to
generate the recombinant plasmid pET32-UL31, which
was confirmed by restriction enzyme analysis (Fig 3C)
and by DNA sequencing. To express the UL31 gene, the
plasmid pET-UL31 was transformed into competent E. coli
BL21(DE3) cells. A high level of expression of the result-
ing 55 kDa recombinant protein was obtained after induc-
tion for 3 h with 0.8 mM IPTG (Fig 3D, lane 2). Based on
the His tag present at its N-terminal end, the recombinant
UL31 was purified by Ni-NTA affinity chromatography
(Fig 3D, lane 3).
Preparation and specificity of anti-UL31 protein antiserum
The anti-UL31 protein antiserum was preparation as
described in Methods. Western blotting experiments were
performed to examine the reactivity and specificity of the
Amino acid sequence comparison between the putative proteins encoded by DEV UL31 and it homologs in hunman herpesvi- ruses: HSV-1 UL31, HCMV UL53, and EBV BFLF2 Figure 2
Amino acid sequence comparison between the putative proteins encoded by DEV UL31 and it homologs in 
hunman herpesviruses: HSV-1 UL31, HCMV UL53, and EBV BFLF2. Sequences were aligned with the Clustalx1.8 
software. Absence of amino acid is shown by dash '-' in the sequences while '*', ':', and '.' Indicate identical amino acid residues, 
conserved residues and semi-conserved residues in all sequence used in the alignment respectively.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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UL31 antiserum. Fig. 4A shows that the UL31 antiserum
reacted with a band in the IPTG induced cell lysates with
an apparent molecular mass of 55 kDa (lane 4). However,
The UL31 antiserum did not react with any proteins
present in uninduced cell lysates (lane 3), nor did the pre-
immune serum react with any proteins present in either
uninduced or induced cell lysates (lanes 5, 6). Therefore,
we used this polyclonal antiserum for further experiments
to characterize the UL31 product of DEV.
To identify the UL31 product, SDS lysates from DEV non-
infected and infected DEF cells were collected and immu-
noblotted with the anti-UL31 polyclonal antibody. As
shown in Fig. 4B, UL31 anti-serum recognized a specific
band of approximately 35 kDa in infected cell lines (lane
3). However, no signal was present in uninfected cell lines
(lane 4). Nucleotide sequence analysis of coding
sequences of UL31 predicts a 35.7 kDa basic protein, and
thus the molecular mass of the protein reacted with the
UL31 antiserum was consistent with that predicted. These
results indicate that the 35 kDa protein is the product of
the DEV UL31 gene.
UL31 RNA expression in infected cells
DEV UL31 RNA expression was analyzed by RT-PCR on
total RNA. As shown in Fig. 5, the UL31 mRNA was detect-
able from 6 h post-infection (p.i.), was markedly
increased at 48 h p.i., indicating that the UL31 gene is
expressed throughout the viral replication cycle and is a
not true late kinetics of expression, in agreement with data
reported for its HSV-1 and ILTV homologues, UL31
[22,25]. The similar expression kinetics may be correlated
with the function of the UL31 gene in different herpersvi-
ruses. PCR samples amplified without reverse transcrip-
tion were negative.
Subcellular location of the UL31 product in DEV-infected 
cells
The intracellular distribution of UL31 protein was exam-
ined by indirect immunofluorescence staining. At 36 h
A Schematic representation UL regions of the DEV genome containing the UL31 gene and strategy for construction of the  expression plasmid pET 32-UL31 Figure 3
A Schematic representation UL regions of the DEV genome containing the UL31 gene and strategy for con-
struction of the expression plasmid pET 32-UL31. B PCR product of the fragment of DEV UL31 detected by 1% agarose 
gel electrophoresis. Lane M, DNA marker; Lane 1, PCR product of the DEV UL31. C DEV UL31 gene encoding DNA 
sequence was cloned into pET 32a(+) prolaryotic expression vector as described in materials and methods. The construct was 
digested with two restriction enzymes. M, DNA marker; Lane 1, BamHI generating one restriction fragment; Lane 2, BamHI 
and HindIII generating two restriction fragments. D Induction of the His-tagged UL31 fusion protien in E. coli. Plasmid pET-
UL31 was transformed into bacteria. Bacteria were grown in the absence (lane 1) or the presence (lane 2) of IPTG. The fusion 
protein was purified as described in Methods (lane 3). Molecular mass markers (in kDa) are shown to the right (lane M). The 
arrowhead indicates the induced UL31 fusion protein.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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(p.i.) postinfection, mock-infected and DEV-infected DEF
cells were fixed and permeabilized as described in Meth-
ods. Then, the cells were treated with bovine serum albu-
min to block nonspecific binding and reacted with the
UL31 antiserum. As shown in picture 6 (F3), the UL31
gene product of DEV is widespread speckled structures in
the nuclei of infected cells. The homologous PRV and
HSV-2 proteins exhibit similar nuclear locations, correlat-
ing with important functions during egress of viral nucle-
ocapsids from the nucleus [14,26,27]. In contrast, no
specific staining was observed in mock-infected cells that
were reacted with the UL31 antiserum (Fig. 6F1) or in
DEV-infected cells reacted with preimmune serum (Fig.
6F2).
The UL31 protein was not detected in extracellular virons
The above results suggest that the UL31 protein may be a
component of DEV virions. To test this possibility, we
next analyzed by Western blotting whether UL31 was
present in extracellular virions. To this purpose, viruses
from infectious supernatants obtained from the DEV-
infected DEF were purified and protein extracts were ana-
lyzed by Western blotting. Fig 7 shows that no reactivity
for UL31 protein was detectable in extracelluar virions
with anit-UL31 bodies, whereas a strong positive signal
was visible in DEV-infected cells, which is in agreement
with the absence of the corresponding gene products from
mature PRV or HSV-1 particles [26,28]. Although we can-
not exclude the possibility that an amount of it too small
to be detected is packaged in virions, these results indi-
cated that the UL31 protein is not a component of DEV
virions.
Distribution of DEV UL31 antigen in DEV-infected ducks
The distribution of DEV UL31 antigen in tissues of artifi-
cially DEV-infected ducks was studied using the immun-
ofluorescence assay (Fig. 8). In the DEV-infected duck
tissues, the UL31 antigen was primarily located in the cells
of immunological organs and digestive organs such as
liver, thymus, myocardiu, bursa, kindey, duodenum, jeju-
num, ileum, cecum, and lung. However, in the other tis-
sues (such as Harders glands, muscle, pancreas, and
cerebrum), the UL31 antigen was less positive signals
(date not shown). In contrast, no positive signals were
located in the tissues of mock-infected ducks. So, we con-
clude that the immunological and digestive organs are tar-
get organs in DEV infections of duck.
Conclusion
In this work, the DEV UL31 gene has been successfully
expressed in a prokaryotic expression system, and we
present the basic properties of the DEV UL31 product. The
results indicate that DEV UL31 shares many similarities
with its HSV or PRV homolog UL31 and suggest that func-
A Expression of pET-UL31 in E. coil and its specificity by Western blot Figure 4
A Expression of pET-UL31 in E. coil and its specificity by Western blot. (a) E. Coil cells harbouring pET 32-UL31 were 
grown in the absence (1) or presnece (2) of IPTG. (b, c) Specificity of rabbit polyclonal antiserum against the His-UL31 fusion 
protein. E. Coil cells harbouring pET 32-UL31 were uninduced (3, 5) or induced (4, 6) with IPTG. Proteins were separated by 
SDS-PAGE and transferred to PVDF membranes. The membranes were incubated with the UL31 antiserum (3, 4) and preim-
mune rabbit serum (5, 6). Arrowheads indicate the UL31 fusion protein. B Identifiction of the UL31 protein by Western 
blot. DEF cells were mock-infected (1, 3) or infected with DEV (2, 4) and harvested at 36 h postinfection (p.i.). Proteins were 
separated by SDS-PAGE and stained with Coomasie brilliant blue (e). UL31 antiserum was used to identify the UL31 protein 
(f). Molecular mass markers (in kDa) are shown to the left (lane M). Arrowhead indicate the UL31 protein.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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tional cross-complementation is possible between mem-
bers of the Alphaherpesvirus subfamily. Furthermore, in
vivo experiments with ducks infected with UL31-defective
isolates of DEV will also be of importance in order to




Duck embryo fibroblasts (DEF) were grown in MEM
medium (Gibco-BRL) supplemented with 10% fetal
bovine serum (FBS) (Gibco-BRL), 100 units/ml penicillin
and 100 μg/ml streptomycin and were used throughout
this study. DEV CHv strain was a high-virulence field
strain isolated from china, obtained from Key Laboratory
of Animal Disease and Human Health of Sichuan Prov-
ince.
Construction of bacterial expression vector
A full-length UL31 gene was amplified by PCR from the
genome of DEV CHv-strain, using synthetic oligonucle-
otide UL31f (5'-AAAGAATTCATGAGCCAGACCCAAC-
CCCCG) as the forward primer and synthetic
oligonucleotide UL31r (5'-TTAGTCGACTACGGCGGAG-
GAAACTCGTC) as the reverse primer. BamH I and Hind
III sites were incorporated into the forward and reverse
primers, respectively. The amplicon was cloned into a T/A
cloning vector (pMD18-T Simple; TaKaRa). The UL31
sequence was subsequently released by BamH I/Hind III
digestion and cloned into the Hind III and BamHI sites of
pET 32a(+) (Novagen) in frame with the gene encoding
His. The recombinant plasmid (pET-UL31) was con-
firmed by restriction enzyme digestion and DNA sequenc-
ing (TaKaRa)
Expression and purification of UL31-His fusion proteins
The confirmed construct described above was used to
chemically transform Escherichia coli BL21(DE3) for
expression the UL31 protein. For production of UL31-His
fusion protein, 100 μl of fresh stationary-phase culture
was inoculated into 10 ml of Luria broth (LB) supple-
mented with 50 μg/ml ampicillin (Sigma). To optimize
expression, the bacterial culture was grown at 37°C until
the optical density at 595 nm was 0.5, at which time pro-
tein expression was induced by the addition of 0.8 mM
isopropyl-β-D-thiogalactopyranoside (IPTG). The culture
was shaken at 210 rpm at 37°C for 3 h in a 100 ml Erlen-
meyer flask. After induction, cells were lysed in 2× sample
buffer (0.1 M Tris-HCl, pH 6.8, 4% SDS, 0.2% bromophe-
nol blue, 20% glycerol, and 0.1 M DTT) and analyzed by
SDS-PAGE [29]. The recombinant His-tagged proteins
were purified by nickel affinity chromatography according
to the manufacturer's protocol (Bio-Rad), and analyzed
by SDS-PAGE.
Character of the UL31 RNA expression in infected DEF Figure 5
Character of the UL31 RNA expression in infected DEF. Total RNA was extracted from the cells for determination of 
UL31 mRNA expression by RT-PCR assays as described in the Methods. The upper panel shows RNA from uninfected DEF 
(UN) and infected DEF at different times p.i. (6, 12, 24, 36, 48, 60 and 72 h), amplified by RT-PCR. Marker: molecular mass 
marker DL2000 (TaKaRa). The lower panel shows β-actin, which was run as an RNA-competence control.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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Generation of polyclonal antisera in rabbits
For the preparation of polyclonal antibodies, male rabbits
were immunized first with 0.5 mg of E. coli-expressed 6×
His-tagged UL31 proteins emulsified in Freund's com-
plete adjuvant. Inoculations were subcutaneous injections
on the shaven back. Freund's incomplete adjuvant and 1
mg of purified fusion protein were used for subsequent
boots. Three booster injections were given each at 1-week
intervals after primary injection. Eighteen days after the
last boot, blood was collected from an ear vessel. Then,
sera were collected and stored at -80°C.
Western blotting
To identify and characterize the DEV UL31 product, DEF,
mock infected or infected with DEV, were harvested by
centrifugation, washed once with PBS, and resuspended
in PBS-1%Triton-2 M urea and briefly sonicated. Then,
samples were denatured and resolved on a 12% SDS-
PAGE gel and transferred onto polyvinylidene difluoride
(PVDF) membrane by standard procedures [30]. For
immunodetection, the membranes were blocked in 5%
nonfat dry milk in PBS-T (0.2% Tween 20 in PBS, PH 7.4)
for 1 h. The membranes were then washed three times
Intracellular location of DEV UL31 protein analyzed by indirect immunofluorescence Figure 6
Intracellular location of DEV UL31 protein analyzed by indirect immunofluorescence. Mock and DEV-infected 
cells were fixed with 4% formaldehyde at 36 h (p.i.) and processed for indirect immunofluorescence. Mock-infected cells with 
UL31 antiserum (F1). DEV-infected cells with preimmune sera (F2) or UL31 antiserum (F3). The cell nuclei were visualized by 
DAPI. (Images were acquired by using 40× objective)Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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with PBS-T and incubated with diluted rabbit anti-UL31
(1:200) sera for 1 h at 37°C. After three washes with PBS-
T, the membranes were incubated with horseradish perox-
idase-linked goat anti-rabbit immunoglobulin G (IgG)
(Amersham) and specific bands were detected using an
enhanced chemiluminescence (ECL system) according to
the manufacturer's instructions (Amersham).
Determination of mRNA expression of UL31 in infected 
cells
The levels of the mRNA transcripts of UL31 were deter-
mined by reverse transcriptase polymerase chain reaction
(RT-PCR) on total RNA, extracted from uninfected or
DEV-infected cells at different times p.i. (6, 12, 24, 36, 48,
60 and 72 h), using the Total RNA Isolation System
(TaKaRa). The concentration of RNA was determined by
measuring A260, and the purity was checked by the A260/
A280 ratio (greater than 1.8). Purified RNA was treated
with DNAase I (TaKaRa) and 2 μg RNA was used as tem-
plate for RT-PCR. The PCR primers for UL31 cDNA and β-
actin cDNA are: UL31 f (5'-GTTGCTGCCCAG TATGTT-3')
and UL31 r (5'-GTCGGATGCTGCTTGTAT-3'); β-actin f
(5'-CCGGGCATCGCTGA CA-3') and β-actin r (5'-GGAT-
TCATCATACTCCTGC TTGCT-3'). cDNA equivalent of 5
ng original RNA was used in PCR. β-actin mRNA expres-
sion was determined using the same amount of cDNA as
an RNA-competence control.
Indirect immunofluorescence assays of infected cells
The DEV UL31 production location in intracellular was
analyzed by Indirect immunofluorescence. DEF cells were
seeded on sterile coverslips and were mock or infected
with DEV. At 36 h postinfection, cells were fixed in 4%
formaldehyde in phosphate-buffered saline (PBS) for 15
min at 25°C and with 0.2%(v/v) TrionX-100 in PBS for an
additional 10 min at 25°C to allow permeabilization. Fol-
lowing several washes in PBS, cells were blocked in 5%
bovine serum albumin (BSA) in PBS for 1 h at 37°C. After,
The cells were reacted with rabbit anti-UL31 serum
diluted 1: 200 in PBS containing 0.1% BSA for overnight
at 4°C, washed three times in PBS and then reacted with
1: 100 dilution of FITC-conjugated goat anti-rabbit
immunoglobulin in PBS containing 0.1% BSA for 1 h at
37°C. The cell nuclei were visualized by DAPI counter-
staining (5 μg/ml, Beyotime). Fluorescent images were
viewed and recorded with the Bio-Rad MRC 1024 imaging
system.
Virion purification
Biochemical characterization of extracellular virions was
performed by precipitating viruses from infectious super-
natants with a polyethylene glycol (PEG)-containing solu-
tion (0.5% [wt/vol] PEG 6000 in 5 M NaCl) as described
previously [17,31,32]. Monolayer of DEF cells were
infected with DEV and harvested from the extracellular
media at 72 h postinfection by centrifugation at 10,000 ×
g  for 20 min. To purify intracellular virions, lytically
induced cells were extensively washed and sequentially
frozen in a dry ice bath and thawed at 37°C three times.
Cells were spun down at 5,000 × g for 10 min, and super-
natants were filtered with a 0.45-μm-pore-size filter.
Viruses present in these supernatants were further PEG
precipitated as described for extracellular virions. Purified
virions were analyzed by Western blotting.
Immunofluorescence image analysis of UL31 antigen 
distribution
To monitor the UL31 antigen distribution in DEV infected
ducks, thirty-day-old ducks (DEV free) were used. The
ducks were divided into 2 groups (A and B): Group B (11
ducks) was mock-infected with PBS by intramuscular
injection; Group A (22 ducks) was infected with DEV (half
of LD50) by intramuscular injection. After 4 d post-infec-
tion, different tissues were obtained and immediately
treated with 4% formaldehyde for 24 h, and then embed-
ded in paraffin.
Four-μm thick histological sections were cut from each tis-
sue, mounted, and baked. They were then deparaffinized
and rehydrated in PBS. For antigen retrieval, the sections
were treated with 0.01 mol/L citrate buffer solution (pH
6.0) for 10 min in a microwave oven. Nonspecific binding
was prevented by treating the sections with 5% bovine
serum albumin (BSA) at 37°C for 30 min. The sections
were then treated with 1:100 diluted anti-UL31 sera for 1
h at 37°C and washed with PBS. Then, they were treated
with FITC – conjugated goat anti-rabbit IgG (1:100).
Slides were washed in three changes of PBS, counter-
stained lightly with Evans blue (EB) (0.01% for 3 min),
Association of the UL31 protein with purified virions Figure 7
Association of the UL31 protein with purified virions. 
DEF infected (1, 4) and uninfected(2,5) cells harvested at 36 
h (p.i.), purified viruses (3, 6) were separated by SDS-PAGE, 
and the gel was stained with Coomasie brilliant blue. Molecu-
lar mass markers (in kDa) are shown to the left (lane M). 
Arrowhead indicate the UL31 protein.Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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Tissue distribution of the UL31 antigen in various organs of DEV-infected ducks Figure 8
Tissue distribution of the UL31 antigen in various organs of DEV-infected ducks. Mock- and infected ducks were 
sacrificed at 4 d post-infection. Each organ was from the ducks and fixed in 4% formaldehyde solution. After fixation, the tissue 
samples were dehydrated and embedded in paraffin. Then the tissue sections were made at 4 μm and stained with an indirect 
immunofluorescent technique. Labels on the left side of the images indicate organs. Negative control is shown in the left col-
umn, and the staining methods are indicated above the top horizontal row. (Images were acquired by using 40× objective).Virology Journal 2009, 6:19 http://www.virologyj.com/content/6/1/19
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dehydrated, and coverslipped. Images were examined
under the Bio-Rad MRC 1024 imaging system.
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